Skip to main content
H.R. 2870 117th Congress House

Essential Medicines Strategic Stockpile Act of 2021

Official title: To amend the Public Health Service Act to provide for stockpiles to ensure that all Americans have access to generic drugs at risk of shortage, and for other purposes.

Introduced: April 28, 2021 Introduced by: Earl L. "Buddy" Carter Republican · Georgia See on congress.gov
Health Business recordsCongressional oversightEmergency medical services and trauma careGovernment information and archives
More subjectsShow fewer subjects
Government studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesPrescription drugsPublic contracts and procurementPublic-private cooperationStrategic materials and reserves
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 29, 2021
Referred to the Subcommittee on Health.
Apr 28, 2021
Referred to the House Committee on Energy and Commerce.
Apr 28, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 29, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Essential Medicines Strategic Stockpile Act of 2021

This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.

Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs.

The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 3

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • BALLARD SPAHR LLP
    for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Pennsylvania · 3rd Quarter 2025 (July 1 - Sep 30)
  • BALLARD SPAHR LLP
    for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Pennsylvania · 2nd Quarter 2025 (Apr 1 - June 30)
  • BALLARD SPAHR LLP
    for CENCORA, INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Pennsylvania · 1st Quarter 2025 (Jan 1 - Mar 31)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2870: Essential Medicines Strategic Stockpile Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2870/
MLA
"H.R. 2870: Essential Medicines Strategic Stockpile Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2870/.
Bluebook (legal)
H.R. 2870, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2870/.
Markdown link
[H.R. 2870: Essential Medicines Strategic Stockpile Act of 2021](https://openamerica.io/bill/117-HR-2870/)
Report a problem